New York State Common Retirement Fund
PCVX icon

New York State Common Retirement Fund’s Vaxcyte PCVX Stock Holding History

New York State Common Retirement Fund’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.73M Buy
150,159
+28,839
+24% +$1.57M 0.01% 843
2026
Q1 		$7.05M Buy
121,320
+4,503
+4% +$244K 0.01% 870
2025
Q4 		$5.39M Sell
116,817
-4,970
-4% -$222K 0.01% 1007
2025
Q3 		$4.39M Sell
121,787
-3,300
-3% -$109K 0.01% 1121
2025
Q2 		$4.07M Sell
125,087
-12,353
-9% -$405K 0.01% 1143
2025
Q1 		$5.19M Buy
137,440
+90,145
+191% +$7.21M 0.01% 1031
2024
Q4 		$3.87M Sell
47,295
-10,086
-18% -$1M 0.01% 1190
2024
Q3 		$6.56M Sell
57,381
-95
-0.2% -$8.56K 0.01% 983
2024
Q2 		$4.34M Buy
57,476
+3,340
+6% +$227K 0.01% 1191
2024
Q1 		$3.7M Sell
54,136
-468
-0.9% -$32.4K ﹤0.01% 1233
2023
Q4 		$3.43M Buy
54,604
+1,170
+2% +$60.8K ﹤0.01% 1251
2023
Q3 		$2.72M Sell
53,434
-40,243
-43% -$1.99M ﹤0.01% 1327
2023
Q2 		$4.68M Buy
93,677
+45,933
+96% +$2.18M 0.01% 1196
2023
Q1 		$1.79M Sell
47,744
-7,408
-13% -$314K ﹤0.01% 1597
2022
Q4 		$2.64M Buy
55,152
+18,292
+50% +$718K ﹤0.01% 1496
2022
Q3 		$885K Buy
36,860
+155
+0.4% +$3.93K ﹤0.01% 2039
2022
Q2 		$799K Buy
36,705
+6,049
+20% +$140K ﹤0.01% 2138
2022
Q1 		$740K Buy
30,656
+2,027
+7% +$44.3K ﹤0.01% 2240
2021
Q4 		$681K Sell
28,629
-105
-0.4% -$2.44K ﹤0.01% 2279
2021
Q3 		$729K Sell
28,734
-5,618
-16% -$136K ﹤0.01% 2257
2021
Q2 		$773K Buy
34,352
+13,252
+63% +$271K ﹤0.01% 2349
2021
Q1 		$417K Buy
21,100
+4,600
+28% +$116K ﹤0.01% 2535
2020
Q4 		$438K Hold
16,500
– – ﹤0.01% 2413
2020
Q3 		$815K Buy
+16,500
New +$657K ﹤0.01% 2010

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

New York State Common Retirement Fund's PCVX Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Vaxcyte (PCVX) stake by 24% in Q2 2026, buying an estimated $1.57M and bringing the position to 150,159 shares worth $8.73M. The position accounts for 0.01% of the portfolio, ranked #843.

New York State Common Retirement Fund first reported a position in PCVX in Q3 2020 and has held it in 24 quarters since. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • New York State Common Retirement Fund held 150,159 shares of Vaxcyte worth $8.73M as of Q2 2026.
  • New York State Common Retirement Fund bought 28,839 Vaxcyte shares in Q2 2026, an estimated $1.57M.
  • Vaxcyte made up 0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #843 holding.
  • New York State Common Retirement Fund first reported a position in Vaxcyte in Q3 2020 and has held it in 24 quarters since.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.